UBS Group’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

UBS Group’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-295,276	Closed	-$29.7M	–	10101
2014 Q4	$29.7M	Buy	+295,276	New	+$23M	0.02%	763

UBS Group's CBST Position: Q1 2015 in Review

UBS Group sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 295,276 shares — an estimated $29.7M sold.

UBS Group first reported a position in CBST in Q4 2014 and held it in 1 quarter. The position peaked at $29.7M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

UBS Group reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
UBS Group sold 295,276 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $29.7M.
UBS Group first reported a position in CUBIST PHARMACEUTICALS INC in Q4 2014 and held it in 1 quarter.
UBS Group's CUBIST PHARMACEUTICALS INC position peaked at $29.7M in Q4 2014.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on UBS Group's 13F filing for Q1 2015, filed 14 May 2015.